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EHRs Connect Research and Practice: Where Predictive Modeling, Artificial Intelligence, and 
Clinical Decision Support Intersect 
 
 
Research highlights 
 
 EHRs are increasingly likely to contain data and functionality that can support computational approaches to 
healthcare. 
 
 Predictive modeling of EHR data has achieved 70-72% accuracy in predicting individualized treatment 
response at baseline. 
 
 Clinical decision support can be conceptualized as a form of artificial intelligence embedded within clinical 
systems. 
 
 Despite challenges, data-driven clinical decision support based on real-world populations offers numerous 
advantages. 
 
 Such approaches may also contribute to better implementation of research into real-world clinical practice. 
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Abstract 
Objectives: Electronic health records (EHRs) are only a first step in capturing and utilizing health-related data – the 
challenge is turning that data into useful information.  Furthermore, EHRs are increasingly likely to include data 
relating to patient outcomes, functionality such as clinical decision support, and genetic information as well, and, as 
such, can be seen as repositories of increasingly valuable information about patients' health conditions and responses 
to treatment over time.   Methods: We describe a case study of 423 patients treated by Centerstone within Tennessee 
and Indiana in which we utilized electronic health record data to generate predictive algorithms of individual patient 
treatment response.    Multiple models were constructed using predictor variables derived from clinical, financial 
and geographic data.   Results:  For the 423 patients, 101 deteriorated, 223 improved and in 99 there was no change 
in clinical condition.    Based on modeling of various clinical indicators at baseline, the highest accuracy in 
predicting individual patient response ranged from 70-72% within the models tested.   In terms of individual 
predictors, the Centerstone Assessment of Recovery Level – Adult (CARLA) baseline score was most significant in 
predicting outcome over time (odds ratio 4.1 + 2.27).  Other variables with consistently significant impact on 
outcome included payer, diagnostic category, location and provision of case management services. Conclusions: 
This approach represents a promising avenue toward reducing the current gap between research and practice across 
healthcare, developing data-driven clinical decision support based on real-world populations, and serving as a 
component of embedded clinical artificial intelligences that “learn” over time. 
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Introduction 
In the modern Information Age, we are often overwhelmed by data.  The challenge is converting that data into 
useful information.
1
   Practitioners and organizations in the healthcare field face this challenge as they strive to 
translate new technological and research advances into clinical advances.  Collecting data in an electronic health 
record (EHR) is only the first step – indeed, we must further leverage that data through technology in order to 
provide useable, actionable information.  Without such additional functionality, EHRs are essentially paper-based 
records stored in electronic form, and their potential to transform care is limited.  Expanding use of EHRs by 
modeling and transforming that data has broad implications for connecting research and practice in the future. 
The lack of actionable, predictive information in healthcare is ironic given that it is a particularly data-rich 
environment. Healthcare is rife with documentation requirements established by payers and accreditation bodies that 
produce much potentially useful information. Managed care companies and disease management vendors have large 
teams of data analysts sifting through health-related claims data (often limited to items such as service date, service 
type, and diagnosis) in order to identify people who may be appropriate for outreach and intervention to prevent 
negative outcomes.  In contrast, many health providers, who produce much richer datasets that include information 
about symptoms, clinical assessments, patient behaviors, and social factors such as SES (socio-economic status), 
level of education, and employment, lack the capacity to analyze and transform such data into actionable 
information. This represents missed opportunities for significant data-driven healthcare improvements based on the 
effective utilization of data in EHRs.  In this paper, we provide an argument and real-world example of what this 
might entail. 
Data-driven healthcare is key for addressing the known 13-17 year gap between research and practice in clinical 
service delivery.
2
  Connecting the processes of collecting data in the course of providing services to ongoing 
modeling efforts could address two problems: evidence-based guidelines derived from research are often out-of-date 
by the time they reach widespread use;  and such guidelines don’t always account for real-world variations and 
comorbidities that can impede effective implementation.
3,4
 While clinicians are receptive to meaningful advances in 
treatment, they are also aware of the complexities they face in daily practice that often are not effectively addressed 
by evidence-based guidelines. For example, guidelines may recommend the same treatment for everyone (i.e., one-
size-fits-all), or prescribe a rigorous, standardized sequence of treatment options.
3,4
 Standardized algorithmic 
approaches to care are clearly effective in research settings; however, clinicians frequently lack the time and 
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information required to make a reliable diagnosis (a prerequisite for many algorithms) and to deal with the minutiae 
of specific treatment recommendations.
5
  
  Concerns that treatment algorithms are inflexible and unresponsive to the needs of real-world clinical 
populations appear to have a basis in fact. A strong allegiance to high fidelity often overshadows the local adaptation 
that often must occur in live clinical practice.  Indeed, even when implemented using technological methods, static, 
one-size-fits-all algorithms do not take full advantage of the technology, or the potential value of the live clinical 
data surrounding them in EHRs.  Such algorithms are essentially “ignorant” of the real-world knowledge sitting 
right next to them – knowledge that could be used to adapt them to their “environment”.  From an evolutionary 
perspective, the end result would likely be extinction.  Not surprisingly, when artificial implementation supports are 
removed, practices often fail to sustain or deviate significantly from fidelity.
6
  
The use of predictive models for informing healthcare treatment algorithms accentuates the tension that exists 
between the art and science of treating common health disorders, between the knowledge of experienced clinicians 
and predictive recommendations derived from data. This old controversy is best characterized by Paul Meehl, who 
noted nearly half a century ago “When you are pushing [scores of] investigations [140 in 1991], predicting 
everything from the outcomes of football games to the diagnosis of liver disease and when you can hardly come up 
with a half dozen studies showing even a weak tendency in favor of the clinician, it is time to draw a practical 
conclusion” (p.372-373).7 
The research-practice gap clearly contributes to the push for clinical decision support in healthcare.  The simple 
concept underlying this effort is that providing decision support to clinicians will improve their decision making, 
leading to better efficiency and quality in care.
8-10
  Decision support, as the name implies, refers to providing 
information to clinicians, typically at the point of decision making.  It comes in a variety of forms
11
 and has also 
been applied to problems related to production, quality, and infrastructure across many fields.
12-14
 However, many 
current decision support systems in healthcare rely on expert- or standards-based models, rather than models that 
adapt population-based guidelines to individual patient characteristics by utilizing existent EHR patient data.  The 
former are based on statistical averages or expert opinion of what works for groups of people in general, whereas 
data-driven models are essentially an individualized form of practice-based evidence drawn from the live 
population.  The latter falls within the concept of “personalized medicine.” 
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There are numerous advantages to building decision support systems driven by live data based on the actual 
population.  The ability to adapt specific treatments to fit the specific symptoms and functional characteristics of an 
individual’s disorder transcends the traditional disease model.  Much of the focus of the past decade has been on the 
utility of genetic data to inform individualized care (a.k.a “personalized medicine”).15,16 However, it is likely that the 
next decade will focus on the use of multiple sources of data – genetic, clinical, socio-demographic – to build a more 
complete profile of the individual, their inherited risks, and the environmental/behavioral factors associated with 
disorder and the effective treatment thereof.
17
  Indeed, this is already apparent in the trend of combining clinical and 
genetic indicators for predicting cancer prognosis.
18-19
 It should be expected that much of this data will be derived 
from 21st century EHRs. 
Improving quality and use of clinical decision support tools requires accurately anticipating the consequences of 
various choices providers make during clinical service delivery.   This entails understanding what indicators are 
important in general, as well as the nuances of what is important in a particular set of circumstances (e.g., the 
impact of alternative treatments on an individual patient’s outcome trajectory).  Predictive modeling and data mining 
(PM/DM) are two interrelated approaches to this issue.  Data mining is the process of discovering patterns in data, 
typically through automatic or semi-automatic means (also sometimes referred to as machine learning).
20
 It can be 
applied to regression and classification problems, identify linear and nonlinear patterns, and adapted to binary or 
multi-class outcomes.  Identified patterns can then be used to make predictions about future events, i.e., predictive 
modeling.  We may want to know what treatment will result in the best outcome, or how staff should be scheduled 
for maximum efficiency. Data mining methods can answer both of these questions.  The end result is actionable 
information for clinicians and managers.   
For instance, we can use historical patients in the existent EHR to identify patterns that can then be applied to 
new clients as they walk in the door (e.g., patterns that typify patients who responded to a particular treatment and 
those who did not).   The PM/DM approach utilizes sophisticated techniques to “decompose” individuals into their 
component characteristics and make targeted predictions based on the probabilities associated with those 
components (in essence creating a composite score from individual component probabilities) – even for individuals 
with novel sets of characteristics – rather than basing predictions on statistical averages or case matching.  The 
measure of the ability to successfully accomplish this is a pragmatic one – the ability to predict accurately on sets of 
instances outside the training sample used to construct the model.
20
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However, data mining or clinical decision support alone is not sufficient for delivering personalized 
recommendations at the point of care.  Utilizing them in conjunction can create a system of real-time data-driven 
clinical decision support, or “adaptive” clinical decision support.   The result is a more responsive and personalized 
model. One advantage of this approach is that the system can improve over time by evaluating its predictions and 
“learning” from its mistakes.  In a sense, this represents a form of artificial intelligence embedded within the live 
clinical system.  An adaptive model can generate and apply new evidence about effective practices every day within 
a live clinical system (i.e., “practice-based evidence”), as well as modify clinically-established guidelines to fit the 
needs of patients in real world settings. 
Continuous improvement of clinical decision support and advancement of clinical knowledge are seen as key 
features for future data systems and EHRs in healthcare.
9
 In terms of actual application, modeling can be used to 
support clinical decisions provided a flexible, adaptable IT framework can consolidate data from different sources.  
Typically, data warehousing provides such an infrastructure to mix rich genetic and clinical data, mine the data, and 
develop algorithms.  In contrast to the EHR, a data warehouse does not have to be tied to a single provider 
organization, and thus enhances the power, scope, and utility of the underlying EHRs.  In many cases, Health 
Information Exchanges (HIEs) can be designed as data warehouses.  Predictive algorithms can be derived from these 
data warehouses as well as the individual underlying EHRs (Fig.1 Time 1) and then be applied to data obtained from 
new patients, with the end result pushed to the front-end web application of the EHR and displayed for clinicians' 
use along with the clinical record (Fig.1 Time 2).  Patterns learned from past patients' experiences can be 
continuously refined as new patients enter the system. 
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Figure 1: Clinical Decision Support - Data Flow Diagram 
 
 
Real-time data-driven clinical decision support narrows the research-practice gap and incorporates the 
idiosyncrasies of the actual clinical population, melding research and practice into the same activity by utilizing 
clinical EHR data in an ongoing basis to create and adapt knowledge.  One is no longer limited to do research, only 
later to try to apply it to practice.  Research becomes practice. 
The following case study demonstrates the challenges and opportunities of utilizing these aforementioned 
methods on EHR data to develop optimal treatment recommendations in a real-world clinical population. 
 
Methods 
A. Setting 
 Centerstone providers in Tennessee and Indiana see over 70,000 distinct patients a year across over 130 
outpatient clinical sites.  Centerstone Research Institute (CRI) is an arm of Centerstone devoted to integrating 
evidence and practice, conducting clinical research, developing clinical decision support tools, and building new 
healthcare informatics technologies, among other goals.  Centerstone, which has a fully functional EHR that 
maintains virtually all relevant patient records, operates under a mixture of fee-for-service and case rate payment 
methodologies, including Medicare, Medicaid, and commercial payers, as well various other payers such as county 
Time 1
Time 2
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subsidies, DCS (Tennessee Dept. of Children Services), federal probation funds, and grants.  Centerstone, like many 
other community mental health providers, is under increasing pressure from all payer sources to hold down costs 
and increase service provision. 
  The initial work described here was necessitated by changes to a state-run payer (non-Medicaid “Safety 
Net”) in Tennessee, which compelled Centerstone to better optimize the match between available services and the 
clinical needs of patients so as to minimize provision of unnecessary services while maximizing outcomes.  We 
approached this requirement by determining the probability that a given set of services would result in average or 
above-average outcomes for a particular patient.  This allowed us to identify services that would provide patients 
with the best probability of positive outcomes while minimizing use of services unlikely to be beneficial, increasing 
the availability of limited resources for other patients. 
B. Data 
 Data was extracted from Centerstone’s electronic health record into a specialized schema in the data 
warehouse for data mining applications.  The target variable was the follow-up CARLA outcome measure 
(Centerstone Assessment of Recovery Level – Adult, http://centerstoneresearch.org/files/CARLA_instrument.pdf) at 
6 months post baseline.  The CARLA is a measure of level of recovery developed and validated by clinical experts 
at Centerstone, informed by recovery levels used by Pike’s Peak Mental Health Center, as well as other level-of-care 
models including ASAM, LOCUS, and Ohio scale.
21
 Using the CARLA, clinicians provide a systematic rating of 
patient symptoms, functioning, supports, insight, and engagement in treatment - a score of 1 indicating severe 
impairment in each dimension and a score of 4 indicating little or no impairment.  Descriptive statistics on CARLA 
at baseline, final (follow-up), and delta (change in health outcome over time) can be seen in Table 1.  Table 2 shows 
frequencies for different categories of change (deterioration, improvement), with roughly 54% showing 
improvement averse to 24% showing deterioration. 
Table 1: Carla Descriptive Stats 
 N Minimum Maximum Mean Std. Deviation 
Baseline CARLA 423 1.2 3.6 2.428 .4069 
Final CARLA 423 1.4 3.8 2.603 .3955 
CARLA Delta 423 -1.0 1.8 .175 .4190 
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Table 2: CARLA Delta Frequencies 
  
Frequency Percent 
Valid 
Percent 
Cumulative 
Percent 
Deteriorated 101 23.9 23.9 23.9 
No Change 99 23.4 23.4 47.3 
Improved 223 52.7 52.7 100.0 
Total 423 100.0 100.0   
 
 Predictor variables initially incorporated into the predictive model included Baseline CARLA Score, 
Gender, Race, Age, Baseline Tennessee Outcomes Measurement System (TOMS) Symptomatology Score, Baseline 
TOMS Functioning Score, Previous Mobile Crisis Encounter (binary, yes/no), Diagnosis Category, Payer, Location, 
County, Region Type (Urban or Rural), Service Profile (types of services received) and Service Volume (amount of 
services received).  The initial sample was delimited to June 1, 2008 through approximately June 1, 2009 and 
included only new intakes at time of baseline CARLA (had not seen previously in Centerstone’s clinics since at least 
2001).  After these various filters were applied and data was screened for missing key fields (such as the CARLA at 
both baseline and follow-up), the final sample size for initial modeling was 423.  Basic demographics of this sample 
can be seen in Table 3 – the patients were largely white, female, and suffering from mood disorders, with a 
significant number (62%) exhibiting co-occurring chronic physical disorders such as chronic pain, high blood 
pressure, diabetes, and cardiovascular disease.  
Table 3: Patient Demographics 
Gender % Race % Age Group % Diagnosis % Locale % 
F 71.3% White 79.5% 18-29 27.4% Anxiety 8.0% Urban 44.4% 
M 28.7% Black 10.1% 30-45 37.7% Bipolar 20.5% Rural 55.6% 
  
 
Asian 0.9% 46-65 31.0% Depression 42.8%     
  
 
Other 1.8% >65 3.9% Other 28.7%     
    Unknown 7.6%             
 
C. Data Mining 
 After the initial data loading and calculations were made, data was loaded into KNIME (Version 2.1.1)
22
, an 
advanced data mining, modeling, and statistical software.  Data mining typically follows a standard process flow 
that can be broken into a number of main steps: data preparation, feature selection, model construction, and model 
evaluation.  It should be noted that not all steps are performed every time – for instance one may build models 
without any feature selection in order to evaluate the effect of feature selection on a particular dataset.  Below, these 
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steps are briefly outlined in the context of the current study; a more comprehensive overview of specific data mining 
strategies and methodology can be found in other resources on the subject.
20,23 
 The first stage is data preparation.  The initial analysis focused on clinical outcomes as measured by the 
change in CARLA scores over time.  The primary question was whether patients would obtain average, better, or 
worse outcomes based on services received.  As such, the target variable was discretized into a binary variable of 
plus/minus the mean (equivalent to an equal bins classification approach).  The consequences and assumptions of 
reduction to a binary classification problem are addressed in Boulesteix et al.,
19
 who noted that the issues of making 
such assumptions are roughly equivalent to those around normal distributions.  All predictor variables were z-score 
normalized.  Subsequently, all predictor variables were either 1) not discretized (labeled “Bin Target”), or 2) 
discretized via CAIM (Class-Attribute Interdependence Maximization).  CAIM is a form of entropy-based 
discretization that attempts to maximize the available “information” in the dataset by delineating categories in the 
predictor variables that relate to classes of the target variable.  Use of patterns in the data itself has been shown to 
improve classifier performance.
24
 It should be noted that not all models are capable of handling both discretized and 
continuous variables, and thus both methods were not applied to all modeling methods.  Additionally, some 
methods, such as certain kinds of neural networks or decision trees, may dynamically convert numeric variables into 
binary or categorical variables as part of their modeling process. 
 Multiple models were constructed on the dataset to determine optimal performance using both native, built-
in KNIME models as well as models incorporated from WEKA (Waikato Environment for Knowledge Analysis; 
Version 3.5.6).
20
 Models were generally run using default parameters, though some experimentation was performed.  
Models tested included Naïve Bayes,
20
 HNB (Hidden Naïve Bayes),
25
 AODE (Aggregating One-Dependence 
Estimators),
26
 Bayesian Networks,
20
 Multi-layer Perceptron neural networks,
20 
Random Forests,
27
 J48 Decision 
Trees (a variant of the classic C4.5 algorithm),
28
 Log Regression, and K-Nearest Neighbors.
20
 Additionally, 
ensembles were built using a combination of Naïve  Bayes, Multi-layer Perceptron neural network, Random Forests, 
K-nearest neighbors, and logistic regression, employing forward selection optimized by AUC (area under the 
curve).
29
  Voting by committee was also performed with those same five methods, based on maximum probability.
30
  
Voting by committee is a meta-modeling technique (like ensemble) that combines multiple models by allowing them 
to “vote” for the winning classification.  It seeks to take advantage of the strengths of different modeling approaches 
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while minimizing their drawbacks.  Due to the number of models used, detailed explanations of individual methods 
are not provided here for brevity, but can be found elsewhere.
20,23
   
 The last step was evaluating model performance to rule out the possibility that statistical findings may be an 
artifact of capitalization on chance, which was performed using 10-fold cross-validation.
20
 All models were 
evaluated using multiple performance metrics, including raw predictive accuracy; variables related to standard ROC 
(receiver operating characteristic) analysis, the AUC (area under the curve), the true positive rate, and the false 
positive rate
31
 and Hand’s H.32  For readers unfamiliar with ROC analysis, it is a form of signal analysis where AUC 
represents the area under the curve of a plot of true positives and false positives (we refer interested readers to the 
excellent introduction on the subject by Fawcett 2004).
31
 The data mining methodology and reporting is in keeping 
with recommended guidelines,
33
 such as the proper construction of cross-validation, incorporation of feature 
selection within cross-validation folds, testing of multiple methods, and reporting of multiple metrics of 
performance, among others.  
Additionally, some better performing models were evaluated using feature selection prior to modeling (but 
within each cross-validation fold).  Feature selection is a key component in filtering out noisy and/or redundant 
variables from datasets and building parsimonious, explanatory models that retain generalizability.  Various methods 
were attempted: univariate filter methods (Chi-squared, Relief-F), multivariate subset methods (Consistency-Based 
–Best First Search, Symmetrical Uncertainty Correlation-Based Subset Evaluator) and wrapper-based (Rank Search 
employing Chi-squared and Gain Ratio).  The advantages and disadvantages of these different types of feature 
selection are well-addressed elsewhere.
34 
 
Results 
 The results of the various combinations of modeling method and discretization can be seen in Table 4, 
sorted by AUC.  The highest accuracies are between 70-72%, with AUC values ranging between .75-.79.  It should 
also be noted that the Spearman’s rank-order correlation between AUC and Hand’s H was .977 (p<.01), indicating 
little divergence between the two measures, at least on this particular dataset.  Hand
32
 has indicated that these two 
measures will diverge when misclassification costs vary across methods.  There was no evidence of that in this case, 
or at least none indicating that the divergence was significant.  These initial results suggest a predictive capacity of 
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the current EHR data within Centerstone.  It is suspected that utilizing more sensitive outcome measures designed to 
specifically measure change over time will improve this capacity. 
Table 4: Model Performance 
10X Cross-Val (partitioned)      
Model Binning Accuracy AUC TP rate FP rate H 
AODE CAIM 72.3% 0.777 74.6% 32.6% 0.274 
Lazy Bayesian Rules CAIM 71.2% 0.774 75.2% 36.2% 0.270 
Naïve Bayes CAIM 71.6% 0.771 76.5% 36.5% 0.271 
Bayes Net - K2 CAIM 70.7% 0.769 75.4% 37.4% 0.255 
Bayes Net - K2 Bin Target 70.4% 0.768 75.7% 38.1% 0.256 
Ensemble CAIM 70.9% 0.760 76.9% 38.1% 0.245 
Naïve Bayes Bin Target 68.6% 0.759 74.7% 41.0% 0.241 
Bayes Net - TAN CAIM 70.0% 0.757 73.3% 37.0% 0.230 
Bayes Net - TAN Bin Target 69.7% 0.756 73.4% 37.6% 0.239 
MP Neural Net CAIM 70.7% 0.753 75.6% 37.6% 0.227 
Ensemble Bin Target 70.2% 0.750 74.5% 37.6% 0.220 
Classif via Linear Reg Bin Target 68.8% 0.749 71.5% 37.6% 0.236 
MP Neural Net Bin Target 69.5% 0.747 73.0% 37.7% 0.237 
K-Nearest Neighbor CAIM 69.5% 0.738 73.6% 38.4% 0.209 
Vote CAIM 68.1% 0.736 72.7% 40.5% 0.201 
Random Forest Bin Target 66.0% 0.724 70.3% 43.1% 0.204 
Random Forest CAIM 67.8% 0.722 71.7% 40.1% 0.190 
Log Regression CAIM 67.8% 0.721 77.7% 47.9% 0.181 
Log Regression Bin Target 67.1% 0.712 71.7% 41.7% 0.180 
J48 Tree CAIM 68.1% 0.681 71.5% 39.4% 0.169 
Vote Bin Target 63.4% 0.661 76.2% 57.1% 0.124 
J48 Tree Bin Target 66.9% 0.654 72.4% 32.6% 0.149 
K-Nearest Neighbor Bin Target 63.8% 0.636 65.9% 44.2% 0.079 
 
 These models were then applied to a series of pre-determined “service packages” that most typical patients 
receive.  The results of one of the higher performing models by AUC (Bayesian Network – K2) were used to 
generate predictive information for the clinician at the time of intake.  Implementation with the live system is being 
addressed in a separate, upcoming study (data not shown).  However, examples of these predictions (based on actual 
data) can be seen in Figures 2 and 3. 
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Figure 2: Example 1 of treatment recommendations using pre-set “service packages” 
 
 
Figure 3: Example 2 of treatment recommendations using pre-set “service packages” 
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 The results of feature selection were mixed (data not shown).  Although some methods were able to 
produce similar performance using smaller, more parsimonious feature sets than the full feature set models (most 
notably wrapper-based approaches), they generally did not improve performance significantly.  Additionally, the 
selected feature sets displayed a marked degree of variability across methodologies.  This is a common issue, to be 
expected with complex problems.
35
 In many domains there are potentially multiple models/feature sets that can 
produce comparably good results.  In terms of individual predictors (as assessed by the chi-squared feature selection 
method), baseline CARLA score was the most significant (Odds Ratio: 4.1, 95% Confidence Interval: 1.83-6.37).  In 
other words, patients with lower baseline scores were 4.1 times more likely to experience above-average outcome 
improvement than those patients with higher baseline scores.   Other variables with consistently significant impact 
included payer (possibly as a proxy for socio-economic status), diagnostic category, county/location, and provision 
of case management services.  However, given the mixed improvement using feature selection and small sample 
size, individual predictor variable performance should be taken with caution at this juncture. 
 
Conclusions 
 Recent years have the seen the proliferation of electronic health records (EHRs) across the mental 
healthcare field and the healthcare industry in general.  The current challenge is turning data collected within EHRs 
into information useful for healthcare providers and addressing the 17-year research-practice gap in healthcare.   
Technology utilizing predictive modeling and data mining has the potential to transform data about the past into 
information about the future to improve clinical care.  Indeed, ongoing research in a large community-based mental 
health provider has produced models that are accurate over 70% of the time (i.e., for 7 out of 10 patients), even 
without enhancing data collected in the EHR specifically for predictive purposes.  Through such an approach the 
potential of EHRs can be realized.  Long term, this will significantly impact the way research is incorporated into 
practice. 
 Predictive modeling can produce tailored recommendations that adapt to variation of real-world 
populations, and even individuals.   New innovations and recommendations for individualized care can literally be 
integrated into predictive models overnight, as opposed to the decades that research evidence often takes to diffuse 
into common practice.   Without individualized care recommendations that have the capacity to rapidly incorporate 
changing evidence, adoption of evidence-based practice and treatment guidelines will likely continue to lag. While 
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there are many barriers to adoption of systematic treatment recommendations, one of the primary failings of 
common treatment recommendations is that they are based on statistical averages (e.g., “70% of people improve 
with medication X”).5 Practicing clinicians are keenly aware that treatments that have been shown to be highly 
effective in clinical trial and research populations are not always directly transferable to individuals in real-world 
settings.  Conversely, data mining models actually benefit from natural variation in clinical practice.  This is a major 
difference between evidence-based models and practice-based evidence, at least as they are currently conceived and 
implemented.  Ultimately, it is likely that greater utilization of evidence-based practices will depend on the 
incorporation of systematic adaptations based on practice-based evidence.  As LW Green noted, “what practitioners 
in clinical, community, and policy-making roles crave, it appears, is more evidence from practices or populations 
like their own, more evidence based in real time, real jurisdictions, typical patients, without all the screening and 
control …”3 
The quickest way to disseminate research findings into practice is to build a framework that allows research 
to be conducted around ongoing clinical practice, without interfering with day-to-day clinical workflow.  The 
research can then be utilized to provide decision support and feedback functionality to clinicians.  We term this 
“adaptive” clinical decision support.  The approach here is moving toward such a framework.  However, it is fraught 
with many challenges.  First, while this paper emphasizes the adaptability of the system, one important consideration 
is the embedding of certain clinical standards around treatment.  In essence, this inserts hard-coded rules into the 
system, holding constant those treatment variables while varying other treatment recommendations around them.  
Indeed, experience at Centerstone has underscored how critical this ability may be to actual clinician adoption.  The 
system also needs to provide information to help support provider decision-making process, providing the right 
information at the right time in the right context.  The principles of mental workload and situational awareness 
(derived from human factors research) are critical in understanding how clinicians may interact with such 
information.   An engaging user interface that can incorporate clinical standards, provide appropriate information, 
and accommodate known human factor issues is key.
36 
 This approach focuses on creating an environment where a clinician’s natural course of adaptation is toward 
data-driven models.  In a sense, it relies heavily on natural evolutionary principles and less on artificial constructs of 
directly altering clinical behavior, the latter of which have been shown to have limited sustainability.
6
 While this 
may be a somewhat atypical approach to implementation, it parallels many current models of behavioral change in 
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psychotherapy, decision support technology implementation, and artificial intelligence.
36-38
  Utilizing an 
evolutionary construct invites application of a wealth of evolutionary models and mathematical constructs that, once 
adapted, may provide an analytical foundation for understanding the process of implementation in general. 
 The greatest challenge to this approach is building meaningful models for clinicians that answer relevant 
questions.  However, it also represents a significant opportunity to delve into more specific questions.  In the work 
described here, the initial model was constructed across all diagnoses - including diagnosis used as a predictor 
variable – but work is proceeding toward construction of models that make personalized clinical predictions within 
diagnostic-specific groups.  Furthermore, we are analyzing more finite considerations of clinical practice, moving 
from – “does the patient need medications?” – to “which medications are most likely to be effective for this 
particular individual?”  Mixing genetic (e.g. microarray) and clinical indicators, rather than using one or the other, is 
the most likely long-term avenue, although if and how these data sources should be combined is still a subject of 
intense debate.
18,19 
 One limitation of this approach is that it requires large populations, diversity in clinical practice, and 
reliable data.  A small medical practice or group practice might not be able to generate enough data to produce 
reliable and replicable findings. It is therefore important for small provider organizations to consider how to 
aggregate their data so that predictive models may be developed and fed back into local EHRs (for instance, via 
Health Information Exchanges [HIEs]).
39
 Privacy and security of health information will be paramount, so as to 
strike the optimal balance between protecting individual privacy and the collective benefit of data aggregation 
toward potential, meaningful advances in care. 
 The case study presented here demonstrated the feasibility of building clinically predictive models using 
data already existent in the EHR.  New studies are currently underway evaluating these approaches with patient-
reported outcomes and for data-driven decision support in controlled pilot settings for patients with depression.
40
 We 
are also developing a national data warehouse to share EHR data across several major mental healthcare providers 
from multiple states, in partnership with Centerstone Research Institute’s Knowledge Network, a technology-based 
alliance of providers, academic researchers, and industry leaders.   Funding is also being sought to develop a gene 
expression database on a large portion of Centerstone’s clinical population, likely starting with patients with 
depressive disorders or schizophrenia.  These efforts aim to improve and validate the approaches laid out herein. 
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 Implementation of EHRs is only the first step in using technology to advance health care, though that first 
step has proven to be challenging.  Indeed, even the popular media is picking up on this fact (“Little Benefit Seen, 
So Far, in Electronic Patient Records” New York Times, 11/15/2009).  Without actually modeling the data, an EHR is 
only informative of what happened in the past, not predictive of what might happen in the future.  Without that 
predictive capacity, it cannot be used by clinicians as actionable information.  In that sense, without predictive 
modeling/data mining, EHRs are essentially just copies of paper-based records stored in electronic form.  There is 
limited expected gain in terms of clinical outcomes, quality, and efficiency.  Predictive modeling/data mining turns 
an EHR into the decision support tool as was envisioned in the beginning, opening doors to possibilities for 
technologies to be built on top of the EHR that can enhance clinical care and improve efficiency.  These 
technologies include behind-the-scenes data infrastructures, warehouses, and potentially national repositories
11
 that 
ultimately merge research and practice into one cohesive process. 
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